FDA approves combination oral contraceptive

Article

The US Food and Drug Administration recently approved Natazia, a 4-phasic combination oral contraceptive containing the progestin dienogest and a synthetic estrogen, estradiol valerate.

The US Food and Drug Administration recently approved Natazia (Bayer HealthCare Pharmaceuticals), a 4-phasic combination oral contraceptive containing the progestin dienogest and a synthetic estrogen, estradiol valerate, which is converted to estradiol in a woman's body. Taken once daily, the dosing regimen consists of pills with varying doses of estradiol valerate and estradiol valerate/dienogest on specific days of a 28-day cycle.

Natazia is licensed in Europe under the brand name Qlaira.

Two multicenter, phase 3 clinical trials conducted in North America and Europe demonstrated the product's safety and efficacy as a combination oral contraceptive. The trials involved 1,867 women and nearly 30,000 28-day cycles. The most common treatment-related adverse effects were irregular bleeding, breast tenderness, headaches, nausea and vomiting, increased weight, and acne.

US Food and Drug Administration. FDA approves new combination product oral contraceptive [press release]. May 6, 2010. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm211176.htm. Accessed June 22, 2010.

Bayer HealthCare Pharmaceuticals. Natazia receives FDA approval–May 6, 2010 [press release]. http://www.natazia.com/scripts/pages/pressrelease.php. Accessed June 22, 2010.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Maria Gallo, PhD, discusses high attendance at crisis pregnancy centers | Image Credit: © x.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.